Discover 878 paid clinical trials in Kentucky. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Kentucky presents diverse clinical research opportunities for healthy volunteers looking to get involved in paid studies, and those with specific health conditions alike. Major research centers in Louisville, Lexington, and Bowling Green are actively seeking participants, offering access to new treatments and advanced medical care.
Filter
1
Filter results
Results: 878
A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
for
Myelodysplastic Syndrome, Anemia
Location: The Bronx NY, Philadelphia PA, Tamarac FL, Atlanta GA,
Sponsor: Takeda
Sex: All
Age: 18+
Code: NCT07422480
Phase 3, Recruiting
A Culturally-Tailored Mobile Health and Social Media Physical Activity Intervention for Improving Physical Activity in Hispanic or Latino/Latina Adolescent and Young Adult Childhood Cancer Survivors, Walking Juntos Study
for
Hematopoietic and Lymphatic System Neoplasm,
Location: New Haven CT, The Bronx NY, Brooklyn NY, Hackensack NJ,
Sponsor: Children's Oncology Group
Sex: All
Age: 15 - 20
Code: NCT06410209
Phase 2, Recruiting
Carnosine for Peripheral Arterial Disease Patients
for
Peripheral Arterial Disease
Location: Louisville KY
Sponsor: Shahid Baba
Sex: Male
Age: 50 - 70+
Code: NCT05371145
Phase 1, Phase 2, Recruiting
Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
for
Castration-Resistant Prostate Carcinoma,
Location: South Weymouth MA, Foxborough MA, Methuen MA,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 18+
Code: NCT06632977
Phase 2, Recruiting
Stress Hydrocortisone In Pediatric Septic Shock
for
Septic Shock
Location: Halifax, Boston MA, Quebec, Livingston NJ, Montreal,
Sponsor: Jerry Zimmerman
Sex: All
Age: 0 - 17
Code: NCT03401398
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
for
Advanced Malignant Solid Neoplasm,
Location: Brewer ME, Augusta ME, Scarborough ME,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 0+
Code: NCT05564377
Phase 2, Recruiting
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
for
Hematologic Malignancies, Inherited Disorders of Metabolism,
Location: Boston MA, New Haven CT, Stony Brook NY, Lake Sucess NY,
Sponsor: Center for International Blood and Marrow Transplant Research
Sex: All
Age: 0+
Code: NCT01351545
Recruiting
Platform of Randomized Adaptive Clinical Trials in Critical Illness
for
Respiratory Insufficiency,
Location: Halifax, Providence RI, Sherbrooke, New York NY,
Sponsor: University Health Network, Toronto
Sex: All
Age: 18+
Code: NCT05440851
Recruiting
Abbott DBS Post-Market Study of Outcomes for Indications Over Time
for
Movement Disorders, Parkinson Disease, Essential Tremor, Tremor,
Location: Albany NY, Tampa FL, Cleveland OH, Columbus OH,
Sponsor: Abbott Medical Devices
Sex: All
Age: 0+
Code: NCT04071847
Recruiting
Testing the Use of Ado-Trastuzumab Emtansine Compared to the Usual Treatment (Chemotherapy With Docetaxel Plus Trastuzumab) or Trastuzumab Deruxtecan for Recurrent, Metastatic, or Unresectable HER2-Expressing Salivary Gland Cancers
for
Metastatic Salivary Gland Carcinoma,
Location: Boston MA, Lebanon NH, Commack NY, Uniondale NY,
Sponsor: NRG Oncology
Sex: All
Age: 18+
Code: NCT05408845
Phase 2, Recruiting
Multi-Center Molecular Diagnosis and Host Response of Respiratory Viral Infections in Pediatric Transplant Recipients
for
Hematopoietic Cell Transplant, Solid Organ Transplant,
Location: Boston MA, The Bronx NY, Washington D.C. DC, Miami FL,
Sponsor: Arkansas Children's Hospital Research Institute
Sex: All
Age: 0 - 18
Code: NCT05550298
Recruiting
Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Ravulizumab Administered Intravenously in Adult Participants at High Risk of Delayed Graft Function After Kidney Transplantation
for
Delayed Graft Function, DGF, Kidney Transplant
Location: New Haven CT, New York NY, Livingston NJ,
Sponsor: Alexion Pharmaceuticals, Inc.
Sex: All
Age: 18+
Code: NCT06830798
Phase 3, Recruiting
Innovations in Personalizing Treatment Study
for
Eating Disorders
Location: Louisville KY
Sponsor: University of Louisville
Sex: All
Age: 18 - 65
Code: NCT06208605
Recruiting
REvascularization CHoices Among Under-Represented Groups Evaluation: The RECHARGE Trial - Minorities
for
Coronary Artery Disease
Location: Boston MA, Flushing NY, Valhalla NY, New York NY,
Sponsor: Weill Medical College of Cornell University
Study of the Theranostic Pair RYZ811 (Diagnostic) and RYZ801 (Therapeutic) to Identify and Treat Subjects With GPC3+ (Glypican-3) Unresectable HCC
for
Hepatocellular Carcinoma (HCC)
Location: New York NY, Baltimore MD, Charlottesville VA,
Sponsor: RayzeBio, Inc.
Sex: All
Age: 18+
Code: NCT06726161
Phase 1, Phase 2, Recruiting
Telavancin Blood and Cerebrospinal Fluid Concentrations in Patients With External Ventricular Drainage
for
Subarachnoid Hemorrhage, Aneurysmal
Location: Lexington KY
Sponsor: Aaron Cook
Sex: All
Age: 18 - 70+
Code: NCT06119061
Recruiting
A Study to Assess the Safety and Risk of Hypersensitivity Reactions of Sulbactam-durlobactam in Adults With Acinetobacter Baumannii-calcoaceticus (ABC) Complex Infection
Location: The Bronx NY, Pittsburgh PA, Tampa FL, Gainesville FL,
Sponsor: Innoviva Specialty Therapeutics
Sex: All
Age: 18+
Code: NCT06746883
Recruiting
Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial
for
Metastatic Clear Cell Renal Cell Carcinoma,
Location: Saint Johnsbury VT, Lebanon NH, Lake Success NY,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT04510597
Phase 3, Recruiting
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
for
End Stage Kidney Disease
Location: Halifax, Portsmouth NH, Boston MA, East Providence RI,